Diabetes Metab J.  2015 Apr;39(2):132-136. 10.4093/dmj.2015.39.2.132.

Selective Immunoglobulin A Deficiency in Type 1 Diabetes Mellitus: A Prevalence Study in Western Sicily (Italy)

• Greco D
• Maggio F

• KMID: 1805896
• DOI: http://doi.org/10.4093/dmj.2015.39.2.132

Abstract

BACKGROUND
The association between type 1 diabetes and immunoglobulin A deficiency (IgA-D) has long been recognized in many populations. The aim of this study was to assess the prevalence of IgA-D in patients with type 1 diabetes mellitus all coming from a defined geographical area and to investigate the clinical features of these subjects.
METHODS
The records of 150 consecutive patients with type 1 diabetes mellitus referred in a period of one year were analyzed. A detailed history was obtained for each patient. Information was collected concerning age, gender, time of onset of diabetes, and presence of other autoimmune diseases.
RESULTS
Out of 150 patients with type 1 diabetes, eight (5.3%) had a diagnosis of IgA-D. There were one female and seven male; all these patients were diagnosed by screening: none of them had history of recurrent infections. Autoimmune thyroiditis was coexisting in five patients (62%). Although other associated autoimmune disorders were found in a number of patients, there was no different prevalence rate in IgA deficient patients.
CONCLUSION
This study shows the prevalence of IgA-D in Sicilian patients with type 1 diabetes as 5.3% which is much higher than reported in other Italian studies. Moreover, our data show a high prevalence of IgA-D in male gender and describe thyroiditis as the most frequent autoimmune disease present in these patients. Finally, in our case report, IgA-D diagnosis always followed routine IgA measurement when case finding for celiac disease with no history of recurrent infections in each patient.

Keyword

Diabetes mellitus, type 1; IgA deficiency; Prevalence

MeSH Terms

Autoimmune Diseases
Celiac Disease
Cross-Sectional Studies*
Diabetes Mellitus, Type 1*
Diagnosis
Female
Humans
IgA Deficiency
Immunoglobulin A*
Male
Mass Screening
Prevalence
Thyroid Gland
Thyroiditis
Thyroiditis, Autoimmune
Immunoglobulin A

Reference

1. Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, Rantapaa-Dahlqvist S, Elvin K, Truedsson L, Andersson BA, Dahle C, Ortqvist E, Gregersen PK, Behrens TW, Hammarstrom L. Selective IgA deficiency in autoimmune diseases. Mol Med. 2011; 17:1383–1396.

2. Yel L. Selective IgA deficiency. J Clin Immunol. 2010; 30:10–16.

3. Ludvigsson JF, Neovius M, Hammarstrom L. Association between IgA deficiency & other autoimmune conditions: a population-based matched cohort study. J Clin Immunol. 2014; 34:444–451.

4. Smith WI Jr, Rabin BS, Huellmantel A, Van Thiel DH, Drash A. Immunopathology of juvenile-onset diabetes mellitus. I. IgA deficiency and juvenile diabetes. Diabetes. 1978; 27:1092–1097.

5. Hoddinott S, Dornan J, Bear JC, Farid NR. Immunoglobulin levels, immunodeficiency and HLA in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1982; 23:326–329.

6. Bertrams J, Schoeps L, Baur MP, Luboldt W, van Loghem E. IgG and IgA heavy chain allotypes in type 1 diabetes. J Immunogenet. 1983; 10:305–310.

7. Cerutti F, Urbino A, Sacchetti C, Palomba E, Zoppo M, Tovo PA. Selective IgA deficiency in juvenile-onset insulin-dependent diabetes mellitus. Pediatr Med Chir. 1988; 10:197–201.

8. Liblau RS, Caillat-Zucman S, Fischer AM, Bach JF, Boitard C. The prevalence of selective IgA deficiency in type 1 diabetes mellitus. APMIS. 1992; 100:709–712.

9. Page SR, Lloyd CA, Hill PG, Peacock I, Holmes GK. The prevalence of coeliac disease in adult diabetes mellitus. QJM. 1994; 87:631–637.

10. Gasparini N, Valerio G, Argenziano A, Salerno M, De Filippo G, Franzese A, Tenore A. Precocious and exaggerated seric IgA production in children affected by IDDM. Diabetes Care. 1996; 19:779–780.

11. Fraser-Reynolds KA, Butzner JD, Stephure DK, Trussell RA, Scott RB. Use of immunoglobulin A-antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes. Diabetes Care. 1998; 21:1985–1989.

12. Acerini CL, Ahmed ML, Ross KM, Sullivan PB, Bird G, Dunger DB. Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten-free diet. Diabet Med. 1998; 15:38–44.

13. Kordonouri O, Dieterich W, Schuppan D, Webert G, Muller C, Sarioglu N, Becker M, Danne T. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with type 1 diabetes mellitus. Diabet Med. 2000; 17:441–444.

14. Schober E, Bittmann B, Granditsch G, Huber WD, Huppe A, Jager A, Oberhuber G, Rami B, Reichel G. Screening by anti-endomysium antibody for celiac disease in diabetic children and adolescents in Austria. J Pediatr Gastroenterol Nutr. 2000; 30:391–396.

15. Picarelli A, Sabbatella L, Di Tola M, Vetrano S, Casale C, Anania MC, Porowska B, Vergari M, Schiaffini R, Gargiulo P. Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus. Clin Exp Immunol. 2005; 142:111–115.

16. Skovbjerg H, Tarnow L, Locht H, Parving HH. The prevalence of coeliac disease in adult Danish patients with type 1 diabetes with and without nephropathy. Diabetologia. 2005; 48:1416–1417.

17. Laadhar L, Zitouni M, Kallel-Sellami M, Masmoudi S, Bouguerra R, Chaabouni H, Ben Slama C, Makni S. Prevalence of celiac disease serological markers in Tunisian type 1 diabetic adults. Ann Biol Clin (Paris). 2006; 64:439–444.

18. Araujo J, da Silva GA, de Melo FM. Serum prevalence of celiac disease in children and adolescents with type 1 diabetes mellitus. J Pediatr (Rio J). 2006; 82:210–214.

19. Sharifi N, Khoshbaten M, Aliasgarzade A, Bahrami A. Celiac disease in patients with type-1 diabetes mellitus screened by tissue transglutaminase antibodies in northwest of Iran. Int J Diabetes Dev Ctries. 2008; 28:95–99.

20. Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S, Sanders DS. High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care. 2011; 34:2158–2163.

21. Sayarifard F, Aghamohammadi A, Haghi-Ashtiani MT, Rajab A, Irani H, Ahmadian JH, Zaridoost A, Parvaneh N, Rezaei N, Rabbani A. Evaluation of serum IgA levels in Iranian patients with type 1 diabetes mellitus. Acta Diabetol. 2012; 49:131–135.

22. Kurien M, Leeds JS, Hopper AD, Wild G, Egner W, Tesfaye S, Hadjivassiliou M, Sanders DS. Serological testing for coeliac disease in type 1 diabetes mellitus: is immunoglobulin A level measurement necessary? Diabet Med. 2013; 30:840–845.

23. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007; 30:Suppl 1. S42–S47.

24. International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies. Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Hammartrom L, Nonoyama S, Ochs HD, Puck J, Roifman C, Seger R, Wedgwood J. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009; 124:1161–1178.

25. Barker JM. Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab. 2006; 91:1210–1217.

26. Collin P, Kaukinen K, Valimaki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev. 2002; 23:464–483.

27. Greco D, Pisciotta M, Gambina F, Maggio F. Celiac disease in subjects with type 1 diabetes mellitus: a prevalence study in western Sicily (Italy). Endocrine. 2013; 43:108–111.

28. Ludvigsson JF, Neovius M, Hammarstrom L. IgA deficiency and mortality: a population-based cohort study. J Clin Immunol. 2013; 33:1317–1324.